Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyperbaric SAC is a private Peruvian medical device manufacturer focused on hyperbaric chambers marketed under the OXICAB brand. The company designs and manufactures monoplace, multiplace, diving/recompression, and veterinary hyperbaric chambers for medical, decompression, and animal-use settings. Its website emphasizes international certifications and compliance with standards such as ASME, NFPA, FDA quality-system requirements for Class II medical devices, ISO 9001, and ISO 13485. Hyperbaric SAC appears to be commercially active, exports to more than 20 countries, and serves hospitals, clinics, diving applications, and select veterinary customers. The business is best characterized as a commercial-stage healthcare equipment manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hyperbaric SAC.